| Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016 |
83 |
| A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis |
37 |
| Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis |
30 |
| Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit |
28 |
| Infectious Complications of Multiple Sclerosis Therapies: Implications for Screening, Prophylaxis, and Management |
26 |
| Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program |
26 |
| Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety |
24 |
| Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016) |
24 |
| Epidemiology and Clinical Features of Invasive Fungal Infection in a US Health Care Network |
23 |
| Phage Therapy for a MultidrugResistant Acinetobacter baumannii Craniectomy Site Infection |
21 |
| Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the Literature |
21 |
| High Morbidity and Mortality Among Patients With Sentinel Admission for Injection Drug Use-Related Infective Endocarditis |
20 |
| Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program |
20 |
| Normal Body Temperature: A Systematic Review |
20 |
| Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population |
19 |
| Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study |
19 |
| Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study |
18 |
| Salvage Debridement, Antibiotics and Implant Retention (DAIR) With Local Injection of a Selected Cocktail of Bacteriophages: Is It an Option for an Elderly Patient With Relapsing Staphylococcus aureus Prosthetic-Joint Infection? |
18 |
| Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997-2016 |
17 |
| Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data |
17 |
| Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and Race |
16 |
| An Assessment of Inappropriate Antibiotic Use and Guideline Adherence for Uncomplicated Urinary Tract Infections |
16 |
| Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study |
15 |
| Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria |
15 |
| Plazomicin Is Active Against Metallo-beta-Lactamase-Producing Enterobacteriaceae |
15 |
| Identification of 19 Novel Hepatitis C Virus Subtypes-Further Expanding HCV Classification |
14 |
| Infectious Diseases Physicians' Perspectives Regarding Injection Drug Use and Related Infections, United States, 2017 |
13 |
| Immunization Mandates, Vaccination Coverage, and Exemption Rates in the United States |
13 |
| Antimicrobial Susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016) |
13 |
| Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016 |
13 |
| Successful Implementation of an Antibiotic Stewardship Program in an Academic Dental Practice |
13 |
| Long-Acting Lipoglycopeptides: Lineless Antibiotics for Serious Infections in Persons Who Use Drugs |
13 |
| Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study |
12 |
| Disparity in Quality of Infectious Disease vs Addiction Care Among Patients With Injection Drug Use-Associated Staphylococcus aureus Bacteremia |
12 |
| Redefining Prevention and Care: A Status-Neutral Approach to HIV |
12 |
| Advancing Patient-Centered Care in Tuberculosis Management: A Mixed-Methods Appraisal of Video Directly Observed Therapy |
11 |
| Changes in Body Mass Index and Atherosclerotic Disease Risk Score After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide |
11 |
| Trends in Kindergarten Rates of Vaccine Exemption and State-Level Policy, 2011-2016 |
11 |
| Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value |
11 |
| Using Machine Learning and the Electronic Health Record to Predict Complicated Clostridium difficile Infection |
10 |
| Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program |
10 |
| Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections |
10 |
| Histoplasmosis, An Underdiagnosed Disease Affecting People Living With HIV/AIDS in Brazil: Results of a Multicenter Prospective Cohort Study Using Both Classical Mycology Tests and Histoplasma Urine Antigen Detection |
10 |
| Epidemiology, Microbiological Diagnosis, and Clinical Outcomes in Pyogenic Vertebral Osteomyelitis: A 10-year Retrospective Cohort Study |
10 |
| The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study |
10 |
| Randomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA-Specified End Points |
10 |
| A Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS Study |
10 |
| No Clinical Benefit to Treating Male Urinary Tract Infection Longer Than Seven Days: An Outpatient Database Study |
10 |
| Patterns of Co-occurring Comorbidities in People Living With HIV |
10 |
| Effect of Commonly Used Pediatric Antibiotics on Gut Microbial Diversity in Preschool Children in Burkina Faso: A Randomized Clinical Trial |
10 |
